Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology Study of DSP-0551 in Japanese Healthy Adult and Elderly Subjects
jRCT2071260023Phase 1Recruiting
- Sponsor
- Sumitomo Pharma
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of DSP-0551 in Parkinson's disease (PD) (6 arms), sponsored by Sumitomo Pharma. Primary endpoints: Safety assessment (Parts A, B, F), Pharmacokinetic assessment (Part C) and 3 more. Started Jun 2026; status: recruiting.
02
Drugs
DSP-0551
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2071260023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260023.